Proteomics
Explore targeted and discovery proteomics panels designed to reveal precise protein-level insights. By integrating proteomics with metabolomics, you can drive more powerful scientific discoveries and seamlessly compare data across studies.
Redefining population health research
Proteomics is transforming population-level health research, offering molecular insights that deepen our understanding of health, disease development, and the biological links that connect diverse conditions.
Each proteomic panel in the Nightingale Health portfolio provides unique strengths. Our experts are here to guide you in selecting the right panels to match your research goals.
When combined with metabolomics, proteomics delivers even greater value – enhancing analytical robustness and opening new scientific opportunities across large-scale studies.
Alamar proteomics panels
Unprecedented biomarker quantitation with ultra sensitive detection.
Unlocking the power of precision proteomics
Alamar’s advanced NULISA proteomics panels deliver exceptional accuracy and sensitivity, enabling reliable measurement of the most clinically and biologically relevant proteins in blood.
These panels are specifically designed to capture ultra low–abundance biomarkers related to brain health, neurodegeneration, and inflammatory cytokine activity providing a comprehensive view of systemic and CNS linked biological processes.
Alamar NULISAseq CNS Disease Panel 120
- Sensitivity meets specificity – one powerful for comprehensive neurodegenerative research
- Includes all emerging Alzheimer’s biomarkers, including best in class brain-derived pTau assays
- Covers broad range of neurodegenerative and neuroinflammatory pathways, suited for e.g. dementia, Parkinson’s, ALS, multiple sclerosis, and brain injury
- Includes dozens of proteins biomarkers of aging
- Absolute quantification 5-plex panel tailored for Alzheimer’s also available
Alamar NULISAseq Inflammation Panel 250
- Deepest profiling of inflammatory response
- Powerful to study aging and any disease with an inflammatory component
- Comprehensive coverage of both innate and adaptive immunity
- Captures numerous specific immune signaling molecules, making it ideal for studies on drug effects
- Absolute quantification panel for 150 of the same proteins also available
Olink proteomics panels
Broadest biological coverage in a single assay.
Powerful, NGS-based proteomics – effortlessly uncover meaningful insights
Olink Reveal and Olink Explore HT panels offer expansive, high resolution proteomic profiling designed to capture proteins relevant to virtually any disease area.
With unmatched coverage across key biological pathways, these panels enable researchers to uncover connections between diseases at the molecular level and accelerate new biomarker discoveries.
Olink Reveal
- Powerful content curated to provide actionable insights
- Covers over 10% of all plasma proteins
- Excellent coverage of immune response, including 100+ cytokine and chemokines ligands and receptors
- Balanced coverage of other pathways, with >60% of all Reactome pathways covered
- Proteins on the panel are included due to proven disease relevance and robust measurement
Olink Explore HT
- Capture true biological insights with proven specificity – at any scale
- One of the most comprehensive proteomics assays: covering around 50% of canonical plasma proteins
- Ideal for broad discovery science where every protein matters such as clinical trials and Gene-vs-protein studies
- Chosen for entire UK Biobank profiling by UKB Pharma Proteomics Project